OrbiMed Provides $100MM Facility to Pharming Group
Dutch pharmaceutical firm Pharming Group replaced its $100 million bridge finance with a $100 million permanent facility agreement. OrbiMed provided both financings.
July 24, 2017
Kreos Capital | OrbiMed Advisors | Pharming Group | Silicon Valley Bank
ABF Journal